Farnum Rhonda sold 13,314 Theravance Biopharma shares in three transactions at $17.03 per share, leaving 213,476 shares after the trades. For investors, the disclosed sale equals about 5.9% of Rhonda’s prior holding, while the transaction record identifies all three disposals with code S.

Key Highlights

  • Farnum Rhonda’s three transactions covered 13,314 Theravance Biopharma shares.
  • Each transaction was priced at $17.03 per share on 15 September 2026.
  • Rhonda held 213,476 shares after the transactions, equivalent to about 5.9% of the prior holding.

Three Transactions at $17.03 Per Share

Theravance Biopharma, Inc. is a biotechnology company. The transactions were dated 15 September 2026 and covered the same per-share price in each entry. The reported pricing range was $17.03 to $17.03 per share, with the aggregate activity spanning 13,314 shares. Theravance identified Farnum Rhonda with the title SVP, COMM & MEDICAL AFFAIRS in connection with the transactions. Following the three entries, Rhonda’s reported ownership stood at 213,476 shares. The transaction record stated that the sale represented about 5.9% of Rhonda’s prior share holding.